Clinical Trial

Impact of Hepatitis B Virus on Inflammatory Bowel Disease

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 18, 2025 (before its estimated May 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this observational retrospective study is to assess the impact of hepatitis B virus (HBV) infection on the clinical course and outcomes of inflammatory bowel disease (IBD) in Egyptian patients. Researchers will compare the IBD extent, location, severity, and behavior between IBD patients with and without HBV infection. Participants will be subjected to history-taking (history of hospital admission and disease flare, surgical history, medication history, follow-up duration, and mortality), clinical examination, laboratory investigations, abdominal ultrasonography, and endoscopic examination.
Trial Details
NCT Number NCT06881238
Lead Sponsor Tanta University
Conditions Inflammatory Bowel Disease (IBD), Hepatitis B Virus
Enrollment 162 participants
Start Date 2024-12-01
Primary Completion 2025-05-30 (estimated)
Study Completion 2025-06-10 (estimated)
Updated on ClinicalTrials.gov 2025-03-18